Abstract: Electrolyte compositions containing a solvent, a co-solvent, certain cyclic carboxylic acid anhydride additives, certain phosphorus-containing additives, and an electrolyte salt are described. The electrolyte compositions are useful in electrochemical cells, such as lithium ion batteries where they provide significantly improved cycle life with no loss of discharge capacity.

Abstract: A lithium-ion battery may include a housing, an anode and a cathode that are disposed in the housing and are in ionically conductive contact with one another, an electrolyte composition that is disposed in the housing and providing an ionically conductive pathway between the anode and the cathode, and a porous separator between the anode and the cathode. The cathode may include a cathode active material which is charged to a potential greater than or equal to 4.35 V versus a Li/Li+ reference electrode. The electrolyte composition may include a) a non-fluorinated carbonate, b) a fluorinated acyclic carboxylic acid ester, c) one or more lithium glycolatoborate compounds, d) a fluorinated carbonate, and e) an electrolyte salt.

Abstract: A lithium-ion battery may include a housing, an anode and a cathode that are disposed in the housing and are in ionically conductive contact with one another, an electrolyte composition that is disposed in the housing and providing an ionically conductive pathway between the anode and the cathode, and a porous separator between the anode and the cathode. The cathode may include a cathode active material which is charged to a potential greater than or equal to 4.35 V versus a Li/Li+ reference electrode. The electrolyte composition may include a) a non-fluorinated carbonate, b) a fluorinated acyclic carboxylic acid ester, c) one or more lithium glycolatoborate compounds, d) a fluorinated carbonate, and e) an electrolyte salt.

Abstract: Disclosed herein are electrolyte compositions comprising: a non-fluorinated carbonate; a fluorinated solvent; a lithium glycolatoborate compound represented by Formula I or Formula II: a fluorinated carbonate; and an electrolyte salt. The electrolyte compositions are useful in electrochemical cells, such as lithium batteries.

Abstract: Electrolyte compositions containing a solvent, a co-solvent, certain cyclic carboxylic acid anhydride additives, certain phosphorus-containing additives, and an electrolyte salt are described. The electrolyte compositions are useful in electrochemical cells, such as lithium ion batteries where they provide significantly improved cycle life with no loss of discharge capacity.

Abstract: Electrolyte compositions comprising novel fluorine-containing carboxylic acid ester solvents are described. The fluorine-containing carboxylic acid ester solvents are represented by the formula R1—C(O)O—R2, wherein R1 is CH3CH2— and R2 is —CH2CHF2, R1 is CH3— and R2 is —CH2CH2CHF2, R1 is CH3CH2— and R2 is —CH2CH2CHF2, R1 is CHF2CH2CH2— and R2 is —CH2CH3, or R1 is CHF2CH2— and R2 is —CH2CH3. The electrolyte compositions are useful in electrochemical cells, such as lithium ion batteries.

Abstract: Electrolyte compositions containing a solvent, a co-solvent, certain cyclic carboxylic acid anhydride additives, certain phosphorus-containing additives, and an electrolyte salt are described. The electrolyte compositions are useful in electrochemical cells, such as lithium ion batteries where they provide significantly improved cycle life with no loss of discharge capacity.

Abstract: Disclosed herein is a fibrous tissue sealant in the form of an anhydrous fibrous sheet comprising a first component which is a fibrous polymer containing electrophilic or nucleophilic groups and a second component capable of crosslinking the first component when the sheet is exposed to an aqueous medium, thereby forming a crosslinked hydrogel that is adhesive to biological tissue. The fibrous tissue sealant may be useful as a general tissue adhesive for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures, tissue repair, and to prevent post-surgical adhesions. The fibrous tissue sealant may be particularly suitable for use as a hemostatic sealant to stanch bleeding from surgical or traumatic wounds.

Abstract: Disclosed herein are electrolyte compositions comprising: a non-fluorinated carbonate; a fluorinated solvent; a lithium glycolatoborate compound represented by Formula I or Formula II: a fluorinated carbonate; and an electrolyte salt. The electrolyte compositions are useful in electrochemical cells, such as lithium batteries.

Abstract: Disclosed herein is a fibrous tissue sealant in the form of an anhydrous fibrous sheet comprising a first component which is a fibrous polymer containing electrophilic or nucleophilic groups and a second component capable of crosslinking the first component when the sheet is exposed to an aqueous medium, thereby forming a crosslinked hydrogel that is adhesive to biological tissue. The fibrous tissue sealant may be useful as a general tissue adhesive for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures, tissue repair, and to prevent post-surgical adhesions. The fibrous tissue sealant may be particularly suitable for use as a hemostatic sealant to stanch bleeding from surgical or traumatic wounds.

Abstract: Electrolyte compositions comprising novel fluorine-containing carboxylic acid ester solvents are described. The fluorine-containing carboxylic acid ester solvents are represented by the formula R1—C(O)O—R2, wherein R1 is CH3CH2— and R2 is —CH2CHF2, R1 is CH3— and R2 is —CH2CH2CHF2, R1 is CH3CH2— and R2 is —CH2CH2CHF2, R1 is CHF2CH2CH2— and R2 is —CH2CH3, or R1 is CHF2CH2— and R2 is —CH2CH3. The electrolyte compositions are useful in electrochemical cells, such as lithium ion batteries.

Abstract: Disclosed herein is a fibrous tissue sealant in the form of an anhydrous fibrous sheet comprising a first component which is a fibrous polymer containing electrophilic or nucleophilic groups and a second component capable of crosslinking the first component when the sheet is exposed to an aqueous medium, thereby forming a crosslinked hydrogel that is adhesive to biological tissue. The fibrous tissue sealant may be useful as a general tissue adhesive for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures, tissue repair, and to prevent post-surgical adhesions. The fibrous tissue sealant may be particularly suitable for use as a hemostatic sealant to stanch bleeding from surgical or traumatic wounds.

Abstract: Method of forming tissue adhesives by reacting an oxidized polysaccharide with a water-dispersible multi-arm polyether amine, wherein at least three of the arms are terminated by primary amine groups, are disclosed. The use of the tissue adhesives for medical and veterinary applications such as topical wound closure; and surgical procedures, such as intestinal anastomosis, vascular anastomosis, tissue repair, and ophthalmic procedures; drug delivery; anti-adhesive applications; and as a bulking agent to treat urinary incontinence are described.

Abstract: Tissue adhesives formed by reacting an oxidized polysaccharide with a water-dispersible multi-arm polyether amine, wherein at least three of the arms are terminated by primary amine groups, are disclosed. The use of the tissue adhesives for medical and veterinary applications such as topical wound closure; and surgical procedures, such as intestinal anastomosis, vascular anastomosis, tissue repair, and ophthalmic procedures; drug delivery; anti-adhesive applications; and as a bulking agent to treat urinary incontinence are described.

Abstract: Disclosed herein is a fibrous tissue sealant in the form of an anhydrous fibrous sheet comprising a first component which is a fibrous polymer containing electrophilic or nucleophilic groups and a second component capable of crosslinking the first component when the sheet is exposed to an aqueous medium, thereby forming a crosslinked hydrogel that is adhesive to biological tissue. The fibrous tissue sealant may be useful as a general tissue adhesive for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures, tissue repair, and to prevent post-surgical adhesions. The fibrous tissue sealant may be particularly suitable for use as a hemostatic sealant to stanch bleeding from surgical or traumatic wounds.

Abstract: Disclosed herein is a fibrous tissue sealant in the form of an anhydrous fibrous sheet comprising a first component which is a fibrous polymer containing electrophilic or nucleophilic groups and a second component capable of crosslinking the first component when the sheet is exposed to an aqueous medium, thereby forming a crosslinked hydrogel that is adhesive to biological tissue. The fibrous tissue sealant may be useful as a general tissue adhesive for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures, tissue repair, and to prevent post-surgical adhesions. The fibrous tissue sealant may be particularly suitable for use as a hemostatic sealant to stanch bleeding from surgical or traumatic wounds.

Abstract: Tissue adhesives formed by reacting an oxidized polysaccharide with a water-dispersible multi-arm polyether amine, wherein at least three of the arms are terminated by primary amine groups, are disclosed. The use of the tissue adhesives for medical and veterinary applications such as topical wound closure; and surgical procedures, such as intestinal anastomosis, vascular anastomosis, tissue repair, and ophthalmic procedures; drug delivery; anti-adhesive applications; and as a bulking agent to treat urinary incontinence are described.

Abstract: Disclosed herein is a fibrous tissue sealant in the form of an anhydrous fibrous sheet comprising a first component which is a fibrous polymer containing electrophilic or nucleophilic groups and a second component capable of crosslinking the first component when the sheet is exposed to an aqueous medium, thereby forming a crosslinked hydrogel that is adhesive to biological tissue. The fibrous tissue sealant may be useful as a general tissue adhesive for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures, tissue repair, and to prevent post-surgical adhesions. The fibrous tissue sealant may be particularly suitable for use as a hemostatic sealant to stanch bleeding from surgical or traumatic wounds.

Abstract: A slush molding process in which the moldable thermoplastic composition powder dosed to the mold is prepared by blending ethylene carboxylic acid copolymers or ionomers with ethylene/glycidyl acrylate or methacrylate copolymer and cross-linking promoter at a temperature and for a time that does not cause significant cross-linking prior to dosing to mold, which is held for sufficient time and temperature to cause cross-linking in-situ, and optionally, other additives including release agents.

Abstract: A slush molding process in which the moldable thermoplastic composition powder dosed to the mold is prepared by blending ethylene carboxylic acid copolymers or ionomers with ethylene/glycidyl acrylate or methacrylate copolymer and cross-linking promoter at a temperature and for a time that does not cause significant cross-linking prior to dosing to mold, which is held for sufficient time and temperature to cause cross-linking in-situ, and optionally, other additives including release agents.